Search

Filters
Clear All
  • 11
  • 16
  • 122

Phase

  • 4
  • 8
  • 19
  • 2
  • 22
  • 1
  • 89
  • 146
  • 33

Found 149 will-simon trials

A listing of will-simon medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

S
Suparna C. Clasen, MD, MSCE
100 years or below
All genders
What is the purpose of this study?The purpose of this study is to determine the incidence and characterize the nature of cardiovascular adverse events occurring following CAR T-cell therapy, including arrhythmia, cardiac ischemia, myocarditis, and heart failure, and the therapeutic modalities used to treat these cardiovascular events. THIS STUDY IS …
S
Sandeep Batra, MD
21 years or below
All genders
What is the purpose of this study?This clinical trial studies cancer survivors to identify those who are at increased risk of developing late-occurring complications after undergoing treatment for childhood cancer. A patient's genes may affect the risk of developing complications, such as congestive heart failure, avascular necrosis, stroke, and second …
P
Patrick Loehrer, MD
1 years - 100 years
All genders
What is this study about?The major purpose of this research study is to obtain blood samples from child and adult patients diagnosed with thymoma and/or tissue samples from patients undergoing surgery for their thymoma.  We will use these specimens to test for certain characteristics that we think will be useful …
T
Theodore Logan, MD
18 years - 100 years
All genders
What is the purpose of this study?The major purposes of this research study is to obtain blood and tissue samples from patients diagnosed with kidney cancer and/or tissue samples from patients undergoing surgery for their kidney cancer and to obtain clinical information. THIS STUDY IS ENROLLING BY INVITATION ONLY - …
S
Scott Coven
10 years or below
All genders
What is the purpose of this study?This research study would like to learn more information about patients who have been diagnosed with medulloblastoma and other CNS embryonal tumors. This research study will compare two different treatment regimens to see which is better for treating your child’s type of brain cancer.Goals·        …
S
Sandeep Batra, MD
49 years or below
All genders
Phase 3
What is the purpose of this study?This phase III trial studies how well active surveillance, bleomycin, carboplatin, etoposide, or cisplatin work in treating pediatric and adult patients with germ cell tumors. Active surveillance may help doctors to monitor subjects with low risk germ cell tumors after their tumor is removed. …
A
Anna Maria Storniolo, MD
110 years or below
All genders
What is the purpose of this study?Adult patients (18 years of age and older) and pediatric patients (younger than 18 years of age) who are being evaluated for and/or treated for cancer at the NIH Clinical Center and at participating sites will be entered onto this tissue procurement protocol for …
J
Jessica MacLean
S
Shadia Jalal, MD
100 years or below
All genders
What is the purpose of the study?The purpose of this study is to examine rare cells called circulating tumor cells that are present in a person's blood when they have lung cancer to see if there is a relationship between a person's cancer symptoms and the number and characteristics of …
 ARE YOU A BREAST CANCER SURVIVOR?  Join Our Study and Help Researchers Learn More About Treating Cognitive Problems Attributed to Chemotherapy
B
Brenna McDonald
18 years - 100 years
Female
ARE YOU A BREAST CANCER SURVIVOR?  HAVE YOU NOTICED ANY PROBLEMS WITH YOUR COGNITIVE FUNCTION - MEMORY, ATTENTION, ABILITY TO MULTI-TASK - AFTER COMPLETING CHEMOTHERAPY? Researchers at Indiana University School of Medicine and the University of Pittsburgh are seeking volunteers to take part in a study looking at two telehealth-delivered therapies …
A
Attaya Suvannasankha, MD
18 years or above
All genders
What is the purpose of this study?Compassionate use access to belantamab mafodotin (GSK2857916) for eligible participants with refractory/relapsing multiple myeloma. Patients considering this access program should have no other therapeutic option, and not eligible for other clinical trials. US patients who have been treated through the REMS program are eligible …
51 - 60 of 149